Abstract

Details of 1123 patients registered in Scotland between 1983 and 1990 for testicular cancer under the Scottish Cancer Registration Scheme were obtained and compared with registrations within the five Scottish oncology centres. Some registration discrepancies were identified. Twenty-eight cancer registrations (2.5%) were coded to the wrong site, 29 patients seen at oncology centres had no cancer registration and 14 cancer registrations had the wrong histology. Five hundred and twenty-seven patients with testicular non-seminomatous germ cell tumours (NSGCT) and 567 with testicular seminoma were identified. Referral rates to specialist oncology centres for testicular germ cell tumours were measured by period and health board area of residence. For the whole study period 92% of NSGCT and 93% of seminoma patients were referred to specialist centres for treatment. Referral rates for different health board areas of residence were not significantly different. This study shows that within Scotland the majority of patients with testicular NSGCT and seminoma are referred to specialist centres, and suggests referral rates of around 92% are underestimates. Access is not related to area of residence.

Highlights

  • Testicular germ cell tumours are the commonest cancer in men aged under 40 in Scotland (Sharp et al, 1993a) and the incidence is increasing

  • Referral rates to specialist oncology centres for testicular germ cell tumours were measured by period and health board area of residence

  • This study shows that within Scotland the majority of patients with testicular nonseminomatous germ cell tumours (NSGCT) and seminoma are referred to specialist centres. and suggests referral rates of around 92% are underestimates

Read more

Summary

Introduction

Testicular germ cell tumours are the commonest cancer in men aged under 40 in Scotland (Sharp et al, 1993a) and the incidence is increasing. Referral patterns within Scotland to specialist oncology centres for patients with testicular germ cell tumours Referral rates to specialist oncology centres for testicular germ cell tumours were measured by period and health board area of residence.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call